Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

John Berdahl

MD

Dr. Berdahl is most motivated by the trust his patients place in him during their moments of vulnerability. That patient trust has, first and foremost, driven him to become an accomplished surgeon. However, as he meets patient needs and learns more about the problems they face, he’s had several opportunities to stretch his skills as an inventor and problem-solver. He co-invented the MKO melt, an innovation used in our Sioux Falls clinic that provides sedation during cataract surgery without the use of an IV or opioids, and developed Interfeen, a rare disease drug that helps with ocular conditions. He created astigmatismfix.com, a resource that has helped tens of thousands of surgeons eliminate residual astigmatism after cataract surgery, and he co-founded ExpertOpinion.MD, a site where patients can request medical opinions from authentic world experts. He also is the founder of Balance Ophthalmics, the first non-surgical, non-pharmacologic way to lower eye pressure for glaucoma treatment, which was FDA approved in 2024. Interests & Added Expertise Dr. Berdahl is equipped to employ the most innovative and tested techniques available to effectively treat most diseases of the anterior segment (front part of the eye). He is exceptionally skilled at diagnosing the best treatment for varying stages of glaucoma, corneal diseases, and cataracts. He is also a meticulous refractive surgeon. To advance the technologies available to our patients, Dr. Berdahl collaborates with numerous ophthalmology companies as a consultant. However, to minimize potential bias, all consulting fees are donated to charity.

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon